What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine-Reference-Cited by-同舟云学术

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

Published:2019-08-23 Issue:9 Volume:16 Page:907-914
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Vorspan Florence¹²,Hjelmström Peter³,Simon Nicolas⁴,Benyamina Amine⁵,Dervaux Alain⁶⁷,Brousse Georges⁸,Jamain Thierry⁹,Kosim Margaux¹⁰¹¹,Rolland Benjamin¹²¹³

Affiliation:

1. Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance Publique – Hôpitaux de Paris, Paris, France

2. Faculté de Médecine, Université Paris Diderot et INSERM UMRS 1144, Université Paris Descartes, Université Paris Diderot, Paris, France

3. Camurus AB, Ideon Science Park, Lund, Sweden

4. INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP, Aix Marseille Univ, Marseille, France

5. CESP, centre d’enseignement, de recherche et de traitement des addictions, université Paris Sud, Villejuif, France

6. Service de Psychiatrie et Addictologie de liaison, CHU Sud, Amiens Cedex, France

7. Groupe de Recherche sur l’Alcool & les Pharmacodépendances (GRAP) INSERM U1247, Amiens, France

8. EA NPsy-Sydo, université Clermont-Auvergne, Clermont-Ferrand, France

9. CSAPA, Maison des Addictions, CPN, Laxou, France

10. Consultations de médecine-Alcoologie PASS, Groupe Hospitalier Pitié Salpêtrière, Paris, France

11. Camurus SAS, Paris, France

12. Service Universitaire d’Addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France

13. Université de Lyon, UCBL1, INSERM, INSERM U1028, CNRS UMR 5292, CRNL, Bron, France

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2019.1649252

Reference58 articles.

1. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010

2. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

3. Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder;Substance Use & Misuse;2023-08-12

2. Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma;Therapies;2023-07

3. The switching process from buprenorphine sublingual tablets to the monthly buprenorphine subcutaneous depot injection in opioid dependent patients;Addiction Biology;2023-04-20

4. Traitements médicamenteux de l’addiction aux opioïdes;Les Addictions;2023

5. Long-acting depot buprenorphine in people who are homeless: Views and experiences;Journal of Substance Abuse Treatment;2022-08